PROCEPT BioRobotics Corp (PRCT) SEC filings

PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value

$23.51+0.17 (+0.73%)

Close on Nov 12, 2026Market cap $1.35BP/E –Yield –

SEC filings

40 of PROCEPT BioRobotics's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 4, 2026	SEC EDGAR
Current report	8-K	Nov 4, 2026	Nov 4, 2026	SEC EDGAR
Current report	8-K	Oct 2, 2026	Oct 2, 2026	SEC EDGAR
Current report	8-K	Sep 23, 2026	Sep 24, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 5, 2026	SEC EDGAR
Current report	8-K	Aug 4, 2026	Aug 4, 2026	SEC EDGAR
Current report	8-K	Jun 9, 2026	Jun 10, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	Apr 30, 2026	SEC EDGAR
Current report	8-K	Apr 29, 2026	Apr 29, 2026	SEC EDGAR
Proxy statement	DEF 14A	Jun 9, 2026	Apr 22, 2026	SEC EDGAR
Current report	8-K	Mar 5, 2026	Mar 6, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 26, 2026	SEC EDGAR
Current report	8-K	Feb 26, 2026	Feb 26, 2026	SEC EDGAR
Current report	8-K	Feb 25, 2026	Feb 25, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 5, 2025	SEC EDGAR
Current report	8-K	Nov 4, 2025	Nov 4, 2025	SEC EDGAR
Current report	8-K	Sep 15, 2025	Sep 18, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	Aug 6, 2025	Aug 6, 2025	SEC EDGAR
Current report	8-K	Jul 23, 2025	Jul 25, 2025	SEC EDGAR
Current report	8-K	Jun 10, 2025	Jun 11, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 2, 2025	SEC EDGAR
Proxy statement	DEF 14A	Jun 10, 2025	Apr 25, 2025	SEC EDGAR
Current report	8-K	Apr 25, 2025	Apr 25, 2025	SEC EDGAR
Current report	8-K	Apr 24, 2025	Apr 24, 2025	SEC EDGAR
Annual report, amended	10-K/A	Dec 31, 2024	Apr 11, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Feb 27, 2025	SEC EDGAR
Current report	8-K	Feb 25, 2025	Feb 25, 2025	SEC EDGAR
Current report	8-K	Oct 29, 2024	Oct 31, 2024	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Oct 28, 2024	SEC EDGAR
Current report	8-K	Oct 28, 2024	Oct 28, 2024	SEC EDGAR
Current report	8-K	Aug 21, 2024	Aug 21, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 2, 2024	SEC EDGAR
Current report	8-K	Aug 1, 2024	Aug 1, 2024	SEC EDGAR
Current report	8-K	Jul 18, 2024	Jul 19, 2024	SEC EDGAR
Quarterly report, amended	10-Q/A	Mar 31, 2024	Jun 27, 2024	SEC EDGAR
Current report	8-K	Jun 4, 2024	Jun 5, 2024	SEC EDGAR
Current report	8-K	May 3, 2024	May 3, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 2, 2024	SEC EDGAR
Current report	8-K	May 1, 2024	May 1, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in PROCEPT BioRobotics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRCT.

Compare: PRCT vs ARAY · PRCT vs ANGO · PRCT vs SKIN · PRCT vs MDXG · PRCT vs LMAT

Revenue growth17.5% · median -4.4%

Gross margin64.7% · median 67.2%

Operating margin-33.6% · median -8.3%

Net margin-32.6% · median -6.3%

Company	Revenue	Growth
ARAY	$394.53M	-12.5%
PRCT	$352.30M	+17.5%
ANGO	$325.38M	+8.2%
MDXG	$303.73M	-22.8%
SKIN	$288.56M	-4.4%
LMAT	$269.36M	+11.8%

Company

Next earnings (est.): Feb 24, 2027, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 888
Held by institutions: 95.8%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1588978

Advertisement
300 × 250

See a number that looks wrong?